Osteoporosis in patients with hepatitis B receiving tenofovir disoproxil fumarate: Does fibroblast growth factor 23 play a role?

Autor: van Oorschot E; Department of Gastroenterology, Geriatrics and Internal Medicine (Co-MIK), Zuyderland Medical Centre, Heerlen-Sittard-Geleen, the Netherlands; Department of Internal Medicine, Division of Infectious Diseases, Maastricht University Medical Centre, the Netherlands. Electronic address: eva.van.oorschot@mumc.nl., Koc ÖM; Department of Gastroenterology, Geriatrics and Internal Medicine (Co-MIK), Zuyderland Medical Centre, Heerlen-Sittard-Geleen, the Netherlands; Department of Gastroenterology and Hepatology, Maastricht University Medical Centre, Maastricht, the Netherlands., Koek GH; Department of Gastroenterology and Hepatology, Maastricht University Medical Centre, Maastricht, the Netherlands.
Jazyk: angličtina
Zdroj: Journal of hepatology [J Hepatol] 2024 Oct; Vol. 81 (4), pp. e196-e197. Date of Electronic Publication: 2024 May 03.
DOI: 10.1016/j.jhep.2024.04.025
Databáze: MEDLINE